Ceftriaxone

Ceftriaxone

Form: Intravenous (IV) and Intramuscular (IM) Injection

Strength: 250 mg, 500 mg, 1 g, 2 g

Reference Brands: Rocephin(US & EU)

Category: Critical Care

Ceftriaxone is a third-generation cephalosporin antibiotic widely used for treating severe bacterial infections, including pneumonia, meningitis, urinary tract infections, gonorrhea, and sepsis. It is administered via intravenous (IV) or intramuscular (IM) injection and is available as a lyophilized powder in 250 mg, 500 mg, 1 g, and 2 g vials. In the US, it is marketed under the brand Rocephin (Roche) and through various generics by Sandoz, Fresenius, and Hikma. In the EU, Rocephin and generic versions by Mylan, Accord, and others are common. Pharma B2B platforms ensure seamless bulk supply of Ceftriaxone to hospitals and clinics.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Glucagon

Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection

Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)

View Details Get Enquiry
Insulin (IV)

Strength: 100 units/mL (U-100) in 10 mL vials

Form: Intravenous (IV) solution

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

View Details Get Enquiry
Flumazenil

Strength: 0.1 mg/mL in 5 mL or 10 mL vials

Form: Intravenous (IV) injection

Reference Brands: Romazicon®(US), Anexate®(EU)

View Details Get Enquiry
Naloxone

Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes

Form: Intravenous (IV) injection/IM/SQ

Reference Brands: Narcan® (US); Narcan® (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.